“Impact of Lebrikizumab on Patient-Reported Outcomes in Atopic Dermatitis: Prospective and Post Hoc Analyses of a Phase 2b Clinical Trial Demonstrate Clinically Meaningful Improvements” (2020) SKIN The Journal of Cutaneous Medicine, 4(6), p. s94. doi:10.25251/skin.4.supp.94.